← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Myofinity Biosciences Inc
Boston, MA
$2,678,753
Total funding
5
Grants
Funding over time
peak $811.4K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,678,753 · 5
By mechanism
R42$1,694,079 · 1
R41$984,674 · 4
Investigators at Myofinity Biosciences Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$811,438
R42 · FY2024 · AR
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$587,105
R42 · FY2025 · AR
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$295,536
R42 · FY2023 · AR
Translational development of novel CRISPR approach to treat genomic duplications$275,651
R41 · FY2023 · AR
Translational development of recombinant protein therapeutic for LGMD2B$259,487
R41 · FY2022 · AR
Optimizing membrane repair for the treatment of Duchenne muscular dystrophy$224,811
R41 · FY2019 · AR
Genome-wide CRISPR screen to identify pro-myogenic factors for cell therapy of DMD$224,725
R41 · FY2018 · AR